Global Canine Tumor Screening Market Growth (Status and Outlook) 2026-2032

January 2026 | 91 pages | ID: G2E81C1BD6B2EN
LP Information

Abstracts

The global Canine Tumor Screening market size is predicted to grow from US$ 426 million in 2025 to US$ 666 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Canine liquid biopsy is a method of analyzing biomarkers in body fluids (such as blood, urine or saliva) to detect the presence of cancer or monitor the progression of cancer. Unlike traditional tissue biopsies, liquid biopsies are non-invasive, fast and convenient. By obtaining a small blood sample, doctors can analyze free DNA, circulating tumor cells, exosomes, etc. to obtain information about the tumor.

United States market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Canine Tumor Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Canine Tumor Screening players cover PetDx, CYTOGEN, BioChain, Small Door, ANGLE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Canine Tumor Screening Industry Forecast? looks at past sales and reviews total world Canine Tumor Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Tumor Screening sales for 2026 through 2032. With Canine Tumor Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Tumor Screening industry.

This Insight Report provides a comprehensive analysis of the global Canine Tumor Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Tumor Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Canine Tumor Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Tumor Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Tumor Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Canine Tumor Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cut Biopsy
• Needle Biopsy

Segmentation by Application:

• Pet Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• PetDx
• CYTOGEN
• BioChain
• Small Door
• ANGLE
• BioChain Institute Inc.
• CANCAN DIAGNOSTICS.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Canine Tumor Screening Market Size (2021-2032)
  2.1.2 Canine Tumor Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Canine Tumor Screening by Country/Region (2021, 2025 & 2032)
2.2 Canine Tumor Screening Segment by Type
  2.2.1 Cut Biopsy
  2.2.2 Needle Biopsy
  2.2.3 Canine Tumor Screening Market Size by Type
    2.2.3.1 Canine Tumor Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Canine Tumor Screening Market Size Market Share by Type (2021-2026)
2.3 Canine Tumor Screening Segment by Application
  2.3.1 Pet Hospital
  2.3.2 Clinic
  2.3.3 Canine Tumor Screening Market Size by Application
    2.3.3.1 Canine Tumor Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global Canine Tumor Screening Market Size Market Share by Application (2021-2026)

3 CANINE TUMOR SCREENING MARKET SIZE BY PLAYER

3.1 Canine Tumor Screening Market Size Market Share by Player
  3.1.1 Global Canine Tumor Screening Revenue by Player (2021-2026)
  3.1.2 Global Canine Tumor Screening Revenue Market Share by Player (2021-2026)
3.2 Global Canine Tumor Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANINE TUMOR SCREENING BY REGION

4.1 Canine Tumor Screening Market Size by Region (2021-2026)
4.2 Global Canine Tumor Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Canine Tumor Screening Market Size Growth (2021-2026)
4.4 APAC Canine Tumor Screening Market Size Growth (2021-2026)
4.5 Europe Canine Tumor Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Canine Tumor Screening Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Canine Tumor Screening Market Size by Country (2021-2026)
5.2 Americas Canine Tumor Screening Market Size by Type (2021-2026)
5.3 Americas Canine Tumor Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Canine Tumor Screening Market Size by Region (2021-2026)
6.2 APAC Canine Tumor Screening Market Size by Type (2021-2026)
6.3 APAC Canine Tumor Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Canine Tumor Screening Market Size by Country (2021-2026)
7.2 Europe Canine Tumor Screening Market Size by Type (2021-2026)
7.3 Europe Canine Tumor Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Canine Tumor Screening by Region (2021-2026)
8.2 Middle East & Africa Canine Tumor Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Canine Tumor Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANINE TUMOR SCREENING MARKET FORECAST

10.1 Global Canine Tumor Screening Forecast by Region (2027-2032)
  10.1.1 Global Canine Tumor Screening Forecast by Region (2027-2032)
  10.1.2 Americas Canine Tumor Screening Forecast
  10.1.3 APAC Canine Tumor Screening Forecast
  10.1.4 Europe Canine Tumor Screening Forecast
  10.1.5 Middle East & Africa Canine Tumor Screening Forecast
10.2 Americas Canine Tumor Screening Forecast by Country (2027-2032)
  10.2.1 United States Market Canine Tumor Screening Forecast
  10.2.2 Canada Market Canine Tumor Screening Forecast
  10.2.3 Mexico Market Canine Tumor Screening Forecast
  10.2.4 Brazil Market Canine Tumor Screening Forecast
10.3 APAC Canine Tumor Screening Forecast by Region (2027-2032)
  10.3.1 China Canine Tumor Screening Market Forecast
  10.3.2 Japan Market Canine Tumor Screening Forecast
  10.3.3 Korea Market Canine Tumor Screening Forecast
  10.3.4 Southeast Asia Market Canine Tumor Screening Forecast
  10.3.5 India Market Canine Tumor Screening Forecast
  10.3.6 Australia Market Canine Tumor Screening Forecast
10.4 Europe Canine Tumor Screening Forecast by Country (2027-2032)
  10.4.1 Germany Market Canine Tumor Screening Forecast
  10.4.2 France Market Canine Tumor Screening Forecast
  10.4.3 UK Market Canine Tumor Screening Forecast
  10.4.4 Italy Market Canine Tumor Screening Forecast
  10.4.5 Russia Market Canine Tumor Screening Forecast
10.5 Middle East & Africa Canine Tumor Screening Forecast by Region (2027-2032)
  10.5.1 Egypt Market Canine Tumor Screening Forecast
  10.5.2 South Africa Market Canine Tumor Screening Forecast
  10.5.3 Israel Market Canine Tumor Screening Forecast
  10.5.4 Turkey Market Canine Tumor Screening Forecast
10.6 Global Canine Tumor Screening Forecast by Type (2027-2032)
10.7 Global Canine Tumor Screening Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Canine Tumor Screening Forecast

11 KEY PLAYERS ANALYSIS

11.1 PetDx
  11.1.1 PetDx Company Information
  11.1.2 PetDx Canine Tumor Screening Product Offered
  11.1.3 PetDx Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 PetDx Main Business Overview
  11.1.5 PetDx Latest Developments
11.2 CYTOGEN
  11.2.1 CYTOGEN Company Information
  11.2.2 CYTOGEN Canine Tumor Screening Product Offered
  11.2.3 CYTOGEN Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 CYTOGEN Main Business Overview
  11.2.5 CYTOGEN Latest Developments
11.3 BioChain
  11.3.1 BioChain Company Information
  11.3.2 BioChain Canine Tumor Screening Product Offered
  11.3.3 BioChain Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 BioChain Main Business Overview
  11.3.5 BioChain Latest Developments
11.4 Small Door
  11.4.1 Small Door Company Information
  11.4.2 Small Door Canine Tumor Screening Product Offered
  11.4.3 Small Door Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Small Door Main Business Overview
  11.4.5 Small Door Latest Developments
11.5 ANGLE
  11.5.1 ANGLE Company Information
  11.5.2 ANGLE Canine Tumor Screening Product Offered
  11.5.3 ANGLE Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 ANGLE Main Business Overview
  11.5.5 ANGLE Latest Developments
11.6 BioChain Institute Inc.
  11.6.1 BioChain Institute Inc. Company Information
  11.6.2 BioChain Institute Inc. Canine Tumor Screening Product Offered
  11.6.3 BioChain Institute Inc. Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 BioChain Institute Inc. Main Business Overview
  11.6.5 BioChain Institute Inc. Latest Developments
11.7 CANCAN DIAGNOSTICS.
  11.7.1 CANCAN DIAGNOSTICS. Company Information
  11.7.2 CANCAN DIAGNOSTICS. Canine Tumor Screening Product Offered
  11.7.3 CANCAN DIAGNOSTICS. Canine Tumor Screening Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 CANCAN DIAGNOSTICS. Main Business Overview
  11.7.5 CANCAN DIAGNOSTICS. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Canine Tumor Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Canine Tumor Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cut Biopsy
Table 4. Major Players of Needle Biopsy
Table 5. Canine Tumor Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Canine Tumor Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Canine Tumor Screening Market Size Market Share by Type (2021-2026)
Table 8. Canine Tumor Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Canine Tumor Screening Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Canine Tumor Screening Market Size Market Share by Application (2021-2026)
Table 11. Global Canine Tumor Screening Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Canine Tumor Screening Revenue Market Share by Player (2021-2026)
Table 13. Canine Tumor Screening Key Players Head office and Products Offered
Table 14. Canine Tumor Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Canine Tumor Screening Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Canine Tumor Screening Market Size Market Share by Region (2021-2026)
Table 19. Global Canine Tumor Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Canine Tumor Screening Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Canine Tumor Screening Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Canine Tumor Screening Market Size Market Share by Country (2021-2026)
Table 23. Americas Canine Tumor Screening Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Canine Tumor Screening Market Size Market Share by Type (2021-2026)
Table 25. Americas Canine Tumor Screening Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Canine Tumor Screening Market Size Market Share by Application (2021-2026)
Table 27. APAC Canine Tumor Screening Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Canine Tumor Screening Market Size Market Share by Region (2021-2026)
Table 29. APAC Canine Tumor Screening Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Canine Tumor Screening Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Canine Tumor Screening Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Canine Tumor Screening Market Size Market Share by Country (2021-2026)
Table 33. Europe Canine Tumor Screening Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Canine Tumor Screening Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Canine Tumor Screening Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Canine Tumor Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Canine Tumor Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Canine Tumor Screening
Table 39. Key Market Challenges & Risks of Canine Tumor Screening
Table 40. Key Industry Trends of Canine Tumor Screening
Table 41. Global Canine Tumor Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Canine Tumor Screening Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Canine Tumor Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Canine Tumor Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. PetDx Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 46. PetDx Canine Tumor Screening Product Offered
Table 47. PetDx Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. PetDx Main Business
Table 49. PetDx Latest Developments
Table 50. CYTOGEN Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 51. CYTOGEN Canine Tumor Screening Product Offered
Table 52. CYTOGEN Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. CYTOGEN Main Business
Table 54. CYTOGEN Latest Developments
Table 55. BioChain Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 56. BioChain Canine Tumor Screening Product Offered
Table 57. BioChain Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BioChain Main Business
Table 59. BioChain Latest Developments
Table 60. Small Door Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 61. Small Door Canine Tumor Screening Product Offered
Table 62. Small Door Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Small Door Main Business
Table 64. Small Door Latest Developments
Table 65. ANGLE Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 66. ANGLE Canine Tumor Screening Product Offered
Table 67. ANGLE Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. ANGLE Main Business
Table 69. ANGLE Latest Developments
Table 70. BioChain Institute Inc. Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 71. BioChain Institute Inc. Canine Tumor Screening Product Offered
Table 72. BioChain Institute Inc. Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. BioChain Institute Inc. Main Business
Table 74. BioChain Institute Inc. Latest Developments
Table 75. CANCAN DIAGNOSTICS. Details, Company Type, Canine Tumor Screening Area Served and Its Competitors
Table 76. CANCAN DIAGNOSTICS. Canine Tumor Screening Product Offered
Table 77. CANCAN DIAGNOSTICS. Canine Tumor Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CANCAN DIAGNOSTICS. Main Business
Table 79. CANCAN DIAGNOSTICS. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Canine Tumor Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Canine Tumor Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Canine Tumor Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Canine Tumor Screening Sales Market Share by Country/Region (2025)
Figure 8. Canine Tumor Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Canine Tumor Screening Market Size Market Share by Type in 2025
Figure 10. Canine Tumor Screening in Pet Hospital
Figure 11. Global Canine Tumor Screening Market: Pet Hospital (2021-2026) & ($ millions)
Figure 12. Canine Tumor Screening in Clinic
Figure 13. Global Canine Tumor Screening Market: Clinic (2021-2026) & ($ millions)
Figure 14. Global Canine Tumor Screening Market Size Market Share by Application in 2025
Figure 15. Global Canine Tumor Screening Revenue Market Share by Player in 2025
Figure 16. Global Canine Tumor Screening Market Size Market Share by Region (2021-2026)
Figure 17. Americas Canine Tumor Screening Market Size 2021-2026 ($ millions)
Figure 18. APAC Canine Tumor Screening Market Size 2021-2026 ($ millions)
Figure 19. Europe Canine Tumor Screening Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Canine Tumor Screening Market Size 2021-2026 ($ millions)
Figure 21. Americas Canine Tumor Screening Value Market Share by Country in 2025
Figure 22. United States Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Canine Tumor Screening Market Size Market Share by Region in 2025
Figure 27. APAC Canine Tumor Screening Market Size Market Share by Type (2021-2026)
Figure 28. APAC Canine Tumor Screening Market Size Market Share by Application (2021-2026)
Figure 29. China Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. India Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Canine Tumor Screening Market Size Market Share by Country in 2025
Figure 36. Europe Canine Tumor Screening Market Size Market Share by Type (2021-2026)
Figure 37. Europe Canine Tumor Screening Market Size Market Share by Application (2021-2026)
Figure 38. Germany Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. France Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Canine Tumor Screening Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Canine Tumor Screening Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Canine Tumor Screening Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Canine Tumor Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 52. APAC Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 53. Europe Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 55. United States Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 56. Canada Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 57. Mexico Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 58. Brazil Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 59. China Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 60. Japan Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 61. Korea Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 63. India Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 64. Australia Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 65. Germany Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 66. France Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 67. UK Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 68. Italy Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 69. Russia Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 70. Egypt Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 71. South Africa Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 72. Israel Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 73. Turkey Canine Tumor Screening Market Size 2027-2032 ($ millions)
Figure 74. Global Canine Tumor Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Canine Tumor Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Canine Tumor Screening Market Size 2027-2032 ($ millions)